Clinical implications of in vitro bleeding test - A review

Infusionstherapie und Transfusionsmedizin

Volumn 24, Issue 6, 1997, Pages 428-434

  Kretschmer, V ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Aspirin von Willebrand's disease; Bleeding time; Platelet disorders; Platelet function

Indexed keywords

ACETYLSALICYLIC ACID; COUMARIN; DESMOPRESSIN; HEPARIN; HEPARINOID; HIRUDIN; ILOPROST; LINSIDOMINE; PHOSPHOLIPID; THROMBOCYTE CONCENTRATE;

BLEEDING TIME; BLOOD CLOTTING DISORDER; HUMAN; HUMAN CELL; IN VITRO STUDY; REVIEW; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOEMBOLISM; VON WILLEBRAND DISEASE;

EID: 0031438730     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Kratzer MAA, Born GVR: Simulation of primary haemostasis in vitro. Haemostasis 1985;15:357-362.
2. Dietrich G, Kretschmer V, Schikor B, Söhngen D: The in vitro bleeding test (IVBT) - A sensitive method for the detection of platelet disorders in platelet donors. Beitr Infusionsther Transfusionsmed, Basel, Karger, 1990, vol 26, pp 142-146.
3. Dietrich G, Kretschmer V: Primary hemostasis in hemodilution 1. influence of the hematocrit. Infusionsther Transfusionsmed 1990;17:212-213.
4. Dietrich G, Kretschmer V: Primary hemostasis in hemodilution 2. influence of various infusion solutions. Infusionsther Transfusionsmed 1990;17:214-216.
5. Dietrich G, Weber D, Kretschmer V: The in vitro bleeding test; standardization of the methodical procedure. Lab Med 1993;17:317-323.
6. Dietrich G, Kretschmer V: Preoperative screening of platelet function with the in vitro bleeding test. Lab Med 1991;15:247 (Abstract).
7. Dietrich GV, Kretschmer V, Weber D, Haupt W, Langen B, Huss B: Variables influencing the Thrombostat 4000: Recommended standardization. Semin Thromb Hemost 1995;21:11-19.
8. Söhngen D, Hattstein E, Heyll A, Meckenstock G, Wienen S, Schneider W: Hematological parameters influencing the Thrombostat 4000. Semin Thromb Hemost 1995;21:20-24.
9. Längle M, Lackner FX, Madritsch M, Schwarz S, Watzl C, Granninger W, Hlozanek C: The influence of high and low molecular hydroxyethyl starch on hemostasis. Anästhesist 1989;38(suppl. 2):586.
10. Kretschmer V, Schikor B, Söhngen D, Dietrich G: In-vitro bleeding test - A simple method for the detection of aspirin effects on platelet function. Thromb Res 1989;56:593-602.
11. Kretschmer V, Schikor B, Söhngen D, Stamm R: A sensitive method for the detection of platelet function impairment of apheresis donors. XX. Congress ISBT, Manchester, 1988, Jas and Carter, abstract P-Th-6-50.
12. Beck K-H, Mohr P, Bleckmann U, Schweer H, Kretschmer V: Desmopressin effect on acetylsalicylic acid impaired platelet function. Semin Thromb Hemost 1995;21(suppl 2):32-39.
13. Beck K-H, Bleckmann U, Mohr P, Kretschmer V: DDAVP's shortening of the bleeding time seems due to plasma von Willebrand factor. Semin Thromb Hemost 1995;21(suppl 2):40-43.
14. Kratzer MAA, Negrescu EV, Hirai A, Yeo YK, Franke P, Siess W: Semin Thromb Hemost 1995;21 (suppl 2):25-31.
15. Ulshöfer B, Dorst V, Kretschmer V, Köhl H, Riedmiller H: Hemostaseological management of urological operations in patients taking Aspirin using the Thrombostat 4000. Semin Thromb Hemost 1995; 21(suppl 2):52-58.
16. Alshameeri RS, Mammen EF: Clinical experience with the Thrombostat 4000. Semin Thromb Hemost 1995;21(suppl 2):1-10.
17. Ronneberger H: The influence of the combined application of phospholipids, prothrombin and Ca ions on the normal and acetylicsalicylic acid induced disturbance of hemostasis in mice and rabbits. Arzneimittel Forsch 1980;30:30.
18. Tilsner V: Efficacy of and therapy with phospholipids to stop hemorrhage in platelet disorders. Beitr Infusionsther Transfusionsmed, Basel, Karger, 1986, vol 15, pp 187-195.
19. Dietrich G, Söhngen D, Kretschmer V: Therapeutic use of phospholipids in thrombocytopenic or thrombocytopathic patients. Semin Thromb Hemost 1995; 21(suppl 2):77-78.
20. Weippert-Kretschmer M, Witte M, Budde U, Vigh T, Kretschmer V, Scharrer I: The Thrombostat 4000 - A sensitive screening test for von Willebrand's disease. Semin Thromb Hemost 1995;21(suppl 2): 44-51.
21. Italian Working Group: Spectrum of von Willebrand's disease: A study of 100 cases. Br J Hematol 1977;35:101-112.
22. Aleskog AE, Killander A, Olsson K, Eriksson L, Kristensen J: Preoperative evaluation of primary hemostasis in patients with thrombocytopenia using the Thrombostat 4000. Semin Thromb Hemost 1995; 21(suppl 2):59-65.
23. Tabuchi N, Tigchelaar I, van Oeveren W: Shear-induced pathway of platelet function in cardiac surgery. Semin Thromb Hemost 1995;21(suppl 2): 66-76.
24. Kretschmer V, Huss B, Feller C, Ponath N, Kiefel V: Influence of HPA-1a and HLA antibodies on primary hemostasis. Semin Thromb Hemost 1995;21: (suppl 2):96-102.
25. Böck M, Groh J, Glaser A, Storck K, Kratzer AA, Heim M: Quality control of platelet concentrates by the Thrombostat 4000. Semin Thromb Hemost 1995; 21(suppl 2):91-95.
26. Högman CF, Eriksson L, Kristensen J: Leukocyte-depleted platelets prepared from pooled buffy coat. Post-transfusion increment and 'in vitro bleeding time' using the Thrombostat 4000/2. Transfus Sci 1993;14:35-39.
27. Kretschmer V, Huss B, Bonacker G, Hoffmann J, Bewarder S, Weber S, Schulzki T, Köppler H, Heimanns J: Thrombocytopenia-adapted in vitro bleeding test assesses platelet function in thrombocytopenic patients. Semin Thromb Hemost 1995;21 (suppl 2):79-90.
28. Kretschmer V, Huss B, Dietrich G, Heymanns J, Pflüger KH: Determination of bleeding risk in thrombocytopenic patients receiving platelet substitution. Transfus Sci 1993;14:27-34.
29. Kretschmer V, Huss B, Weber S, Bewarder S, Schulzki T, Köppler H, Heimanns J: A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy. Transfus Sci 1994;15:361-369.
30. Hoffmann J, Bonacker G, Kretschmer V, Schulzki T, Heimanns J: IVBT-documented platelet function correlates with flow cytometric data. Transfus Sci 1995;17:553-558.
31. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA: Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995;21(suppl 2):106-112.
32. Mammen EF, Alshameeri RS, Comp PC: Preliminary data from a field trial of the PFA-100™ system. Semin Thromb Hemost 1995;21(suppl 2):113-121.
33. Weippert-Kretschmer M, Möller A, Kretschmer V: Platelet function analyzer (PFA-100™) for screening of von Willebrand disease (vWD). Ann Hematol 1997;74(suppl 2):A147 (Abstract).
34. Borries M, Söhngen D, Englisch C Schoebel FC, Stein D, Fischer Y, Boogen C, Strauer BE, Leschke M: Platelet activation in patients with coronary artery disease before and after PTCA and aspirin medication. Ann Hematol 1997;74(suppl 2):A73 (Abstract).
35. Borries M, Söhngen D, Englisch C, Schoebel FC, Stein D, Stiegler H, Boogen C, Strauer BE, Leschke M: Measurement of aspirin and ticlopidine on platelet function with a simple in vitro bleeding test. Ann Hematol 1997;74(suppl 2):A137 (Abstract).
36. Müller M, Becker-Hagendorff K, Wetsrup D, Seifried E, Kirchmaier CM: PFA-100™ system: A sensitive test for the detection of platelet function disorders. Ann Hematol 1997;74(suppl 2):A78 (Abstract).
37. Loreth RM, Berger HH, Albert FW: Investigations to an increased primary hemostasis in the venous occlusion test with the PFA-100™. Ann Hematol 1997;74(suppl 2):A79 (Abstract).
38. Wilmer M, Sio R, Kolde H-J, de Haan J: Characterization of preanalytic and technical variables using the PFA-100™ test system. Ann Hematol 1997;74 (suppl 2):A117 (Abstract).
39. Van Pape KW, Wuttke M, Dölp R, Bohner J: Determination of the platelet function with the PFA-100™ test system. Ann Hematol 1997;74(suppl 2):A118 (Abstract).